Incobotulinumtoxin A is under clinical development by Merz Therapeutics and currently in Phase II for Unspecified Musculoskeletal Disorders.

The drug candidate was also under development for treatment of snoring, notalgia paresthetica, brachial plexus neuritis, lateral epicondylitis, rosacea, focal cancer pain, foot dystonia in parkinson ...

You may also hear this type of seizure called a partial seizure. You can find out about focal seizures on our webpage. Someone having a focal seizure may not be aware of their surroundings or what ...